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Abstract
Background: Coenzyme Q (CoQ) is a lipophilic antioxidant that is synthesized by a mitochondrial complex integrated by at
least ten nuclear encoded COQ gene products. CoQ increases cell survival under different stress conditions, including
mitochondrial DNA (mtDNA) depletion and treatment with cancer drugs such as camptothecin (CPT). We have previously
demonstrated that CPT induces CoQ biosynthesis in mammal cells.
Methodology/Principal Findings: CPT activates NF-kB that binds specifically to two kB binding sites present in the 59-
flanking region of the COQ7 gene. This binding is functional and induces both the COQ7 expression and CoQ biosynthesis.
The inhibition of NF-kB activation increases cell death and decreases both, CoQ levels and COQ7 expression induced by CPT.
In addition, using a cell line expressing very low of NF-kB, we demonstrate that CPT was incapable of enhancing enhance
both CoQ biosynthesis and COQ7 expression in these cells.
Conclusions/Significance: We demonstrate here, for the first time, that a transcriptional mechanism mediated by NF-kB
regulates CoQ biosynthesis. This finding contributes new data for the understanding of the regulation of the CoQ
biosynthesis pathway.
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Introduction
Coenzyme Q (CoQ) is a small lipophilic molecule that
transports electrons from mitochondrial respiratory chain com-
plexes I and II, to complex III [1]. In addition, CoQ functions as a
cofactor for uncoupling proteins [2] and other mitochondrial
dehydrogenases [1]. CoQ mainly acts as an antioxidant and can
prevent cell death under certain stress conditions, particularly in
mitochondria-DNA depleted cells [3,4]. CoQ also regulates the
extracellulary induced ceramide-dependent apoptotic pathway
[5]. CoQ is composed of a benzoquinone ring and a poly-
isoprenoid chain, derived from tyrosine and mevalonate, respec-
tively. Its biosynthesis depends on a pathway that involves at least
ten genes (COQ genes). Among them, COQ7 is proposed to
encode for a key regulatory component of a multisubunit enzyme
complex [6]. However, there is no information about the precise
regulation of CoQ biosynthesis pathway except that peroxisome
proliferator-activated receptor alpha (PPARa) is involved [7].
We have previously shown that Campothecin (CPT) treatment
increases CoQ biosynthesis rate and reported that CPT in
mammals up-regulates COQ7 [8]. Thus, the stimulation by CPT
is a useful tool for deciphering transcriptional mechanisms of the
regulation of the CoQ biosynthetic pathway in mammals through
up-regulation of COQ7 gene.
Camptothecin (CPT) is a cytotoxic drug widely used in cancer
therapy. It is known that the main target for camptothecin is the
nuclear topoisomerase I (TOP1) [9–11]. Double-strand DNA
breaks derived from the inhibition of nuclear TOP1 are
considered the main cause of apoptosis induction by CPT [11].
CPT also induces an increase of reactive oxygen species (ROS) in
different cancer cell lines including H460 cells [12,13,14,15,16,8].
There are recent reports supporting the role of oxidative stress in
the induction of apoptosis by CPT and its derivatives [15,17]. In
response to topotecan, a CPT water-soluble derivative, cells activate
their antioxidant defense mechanisms and a number of antioxidant
enzyme activities, such as catalase, manganese-dependent superox-
ide dismutase (MnSOD), and glutathione peroxidase [16]. Also, the
addition of catalase was able to protect cells from CPT induced
apoptosis in HL-60 leukemia cells [12]. Furthermore, catalase
administration to U-937 promonocytic cells also attenuated
apoptosis induction by CPT and other cytotoxic drugs [18]).
NF-kB is a redox-sensitive transcription factor, which regulates
antioxidant enzymes such as MnSOD encoded by the SOD2
gene. NF-kB is also activated by CPT in several cell types [19–22].
In fact, NF-kB activation is frequently abrogated by antioxidants
[23,24]. NF-kB has been shown to play a key role in the regulation
of cell death, either as inducer or, more often, as blocker of
apoptosis, depending on the cellular type and the insult [25,26].
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5301Thus, we have proposed that NF-kB could be one of the mediators
of the cellular effects by CPT through the activation of the CoQ
biosynthesis pathway.
Results
CoQ biosynthesis is dependent on NF-kB
Oxidative stress rises as an important activator of NF-kB that
can be abrogated by antioxidants [23,24]. We have previously
demonstrated that in H460 cells, which were blocked in the CoQ
biosynthesis pathway, exhibited a increased sensitivity to produc-
tion of ROS and cell death induced by CPT [8].
H460 cells treated with 10 mM CPT for 24 hours were fixed and
probed with p65 antibody to confirm that the NF-kB system is
active in these cells. Immunofluorescence experiments showed that
the transcription factor translocated into the nucleus in response to
CPT (figure 1 A).
In order to test whether NF-kB elicits a survival response in
H460 cells and if the induction of CoQ biosynthesis in CPT
treated cells is dependent on NF-kB activation, cell viability and
cellular CoQ levels were measured in the presence of Bay 11-7085,
a specific inhibitor of NF-kB [27]. The inhibition of NF-kB
increased cell death and reduced CoQ levels induced by CPT
(figure 1 B and C). In parallel, we observed that the increase of
COQ7 mRNA measured by real time PCR in CPT treatments was
significantly abolished by Bay 11-7085 (figure 1 D), suggesting a
dependence of COQ7 gene to NF-kB.
It has previously been reported that NF-kB system is down-
regulated in DU145 RC0.1, a cell line resistant to CPT [28]. We
used parental DU145 and RC0.1 cells to evaluate protein levels of
the NF-kB system components p65 and IkBa and observed a very
low content in RCO.1 compared to parental cells (figure 2 A).
In RC0.1 cells, CPT treatment induced a higher production of
ROS compared to parental DU145 and H460 cells (figure 2 B).
Since mitochondrial ROS generation stimulated by CPT is
responsible for the induction of CoQ biosynthesis, CoQ levels
and COQ7 mRNA were measured in both parental DU145 and
RC0.1 cell lines after 10 mM CPT treatment for 24 h. The
parental DU145 cell line showed an increase in both CoQ levels
and COQ7 messenger in response to CPT. However, the RC0.1
cells showed only a trend to increase CoQ levels and COQ7
messenger figure 2 C and D). Since the NF-kB system is down
regulated in RC0.1 cells, this finding would confirm the
requirement of NF-kB to CPT induced CoQ biosynthesis.
Figure 1. CPT activates NF-kB in H460 cells. A. H460 cells were treated, fixed and permeabilized. Immunostaining with p65 antibody shows a
cytosolic distribution of the protein in control cells and a clear nuclear localization when treated with 10 mM CPT. B. Effect of the inhibitor of NF-kBo n
cell sensitivity to CPT. H460 viability was tested by cytometric analysis of PI incorporation. * P,0.05 between treatments and their controls C. Effect of
the presence of the inhibitor Bay 11-7085 (BAY) on the CPT dependent increase in CoQ levels. Results are the mean6SD of three independent
experiments. * P,0.05 between control and the CPT -treated group. D. Relative expression of COQ7 gene measured by real time PCR. Results are
normalized on the basis of the expression of the housekeeping actin gene. Results are the mean6SD of three independent experiments; * P,0.05.
doi:10.1371/journal.pone.0005301.g001
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Transcription element search software (TESS) sequence analysis
[29,30] of 4 Kb of the 59-flanking region, exon 1 and the
beginning of the first intron of the human COQ7 gene revealed two
potential binding sites for NF-kB, three for Sp1, as well as one for
RXR (figure 3). The same analysis revealed other putative
binding sites but we decided to focus on those potentially related to
the oxidative stress response, particularly NF-kB because it is a
redox-sensitive factor that has been shown to be activated by CPT
[19]. One of the putative NF-kB binding sites, kB1 site, was found
in the promoter region of the gene (position 2360 to 2350)
whereas the second one, kB2, was identified at the beginning of
the first intron of the gene (position +120 to +131).
Electrophoretic mobility shift assays were performed to evaluate
the binding of the NF-kB transcription factor to the hypothetical
binding sites found in COQ7 gene. Nuclear extract from CPT
treated cells were incubated with digoxigenin-labeled oligonucle-
otides encompassing kB1 or kB2 putative binding sites. The
incubation with kB1 probe generated a band shift in response to
CPT treatment (figure 4 A). The intensity increase of the shifted
band achieved significance after 1 hour of treatment. Competition
assays with an excess of either unlabeled normal or nonspecific
oligonucleotides confirmed the specificity of the binding (figure 4
B). In addition, competition assays using antibodies against diverse
subunits of NF-kB were also performed. Anti p50 impaired the
formation of the protein-DNA complex. However, it failed to react
with anti p65 and anti p52 sera (figure 4 C).
We assayed the time course binding of NF-kBt okB2 site
(figure 5 A). Incubation of the kB2 probe with nuclear extracts of
CPT treated cells resulted in a band shift that reached a maximum
intensity at 6 hours of treatment. In order to demonstrate that the
in vitro NF-kB binding to kB2 was specific and that the
composition of the heterodimer was p65/p50 we ran competition
(figure 5 B) and super-shift assays (figure 5 C).
Our results strongly support the in vitro specific binding of NF-
kB to both sites in the COQ7 sequence in response to CPT.
Figure 2. Effect of CPT on DU145 RC0.1 cells. A. Protein levels of the NF-kB system components p65 and IkBa on parental DU145 and RC0.1 cell
lines. Cytosolic protein extracts from DU145WT (1 and 2) and RC0.1 (3 and 4) cells were separated on a 10% polyacrilamide gel and immunostained
with antibodies against IkBa, p65 and actin. B. CPT-induced early generation of ROS. Cells were treated during the indicated times with 10 mM CPT.
ROS were determined by flow cytometry by using H2DCF-DA. Results are expressed as mean6SD of three independent experiments; * P,0.05. C.
CoQ levels of DU145 cell lines in response to 10 mM CPT. Parental DU145 and RC0.1 were treated with CPT for 24 hours and CoQ levels were
determined as described under Material and Methods. * P,0.05 between control and the CPT -treated group. D. COQ7 mRNA relative levels from
parental DU145 and RC0.1 cells treated for 24 h with 10 mM CPT. Results are expressed as mean6SD of three independent experiments. * P,0.05
between control and the CPT -treated group.
doi:10.1371/journal.pone.0005301.g002
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To evaluate the physiological importance of the COQ7 kB
binding sites, firefly luciferase reporter constructs containing
several regions of the COQ7 59-flanking sequence (figure 6 A)
were transfected into HeLa cells. We have previously demon-
strated that CPT also induces cell death and stimulates CoQ
biosynthesis in HeLa cells [8]. Transfected cells were treated with
10 mM CPT and their luciferase activity was measured. Results
represent firefly luciferase activity normalized on the basis of the
constitutive b-gal activity of a control vector that was co-
transfected. Three hours of CPT treatment induced a significant
increase in the reporter activity when pGL3-2 construct was
assayed. Reporter assays performed with pGL3-1 construct, with
a deletion of 1150 bp in 59, did not show response to CPT
(figure 6 B). These data then suggest that it is necessary a large
region consisting of at least 2770 bp are required for COQ7 to
respond to CPT. The presence of the NF-kB inhibitor Bay 11-
7085 during the CPT treatment of the transfected cells
completely abolished the induction of the reporter gene
expression (figure 6 B).
To further understand the system, deletions of seven bp inside
the kB binding sites were made to generate the pGL3-2kB1,
pGL3-2kB2 and pGL3-2kB1+kB2 plasmids. None of the
constructs responded to CPT (figure 6 C), suggesting that both
binding sites are necessary for the transcriptional induction of
COQ7 in response to CPT.
To determine which IkB isoform was involved in the NF-kB
activation by CPT, cytosolic levels of both isoforms were
determined by western blot. Both IkBa and IkBb were degraded
following the CPT treatment, which was prevented by Bay 11-
7085. On the other hand, Bay 11-7085 also inhibited the nuclear
translocation of NF-kB subunit p50 (figure 6 D).
Figure 3. Nucleotide sequence of the 59-flanking region of the human COQ7 gene. Colored boxes indicate putative binding sites for diverse
transcription factors: red and light blue boxes encompass kB1 and kB2 sites respectively; yellow boxes delimit hypothetical Sp1 binding sites and the
green box a possible binding site for RXR. Guanine in red indicates the transcriptional start site.
doi:10.1371/journal.pone.0005301.g003
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The lipidic antioxidant CoQ is considered a central component
of the antioxidant defense, protecting cells from membrane
peroxidations and regenerating the reduced forms of exogenous
antioxidants [31]. CoQ has also been proposed to prevent
apoptosis derived from oxidative stress induced by different
stimuli [32,33].
The details about the CoQ biosynthesis pathway are unfolding.
There are at least ten genes (COQ) involved in a complex
biosynthetic pathway [34,6]. However, there is still little
knowledge about its regulation [1], except that CoQ biosynthesis
is activated in mouse liver by the nuclear regulator PPARa [35].
As the number of identifiable human pathologies that are
associated with a primary CoQ deficiency increases, there is a
need for the full understanding of its biosynthetic pathway, from
the proteins participating in the enzymatic process, to the
regulatory mechanisms [36].
We have previously shown that CPT induces the up-regulation
of COQ7 [8], which is considered to have both a regulatory and
kinetic role in CoQ biosynthesis [37,6]. Thus, we have focused on
the regulatory mechanisms of COQ7 expression as a marker of
CoQ biosynthetic pathway transcriptional regulation. Searching
for putative binding sequences for known transcription factors we
have identified two hypothetical binding sites for NF-kB through
the analysis of the COQ7 59 sequence using TESS program based
on TRANSFACT database v6.0 [29,30].
NF-kB activation has been observed in diverse physiological
processes including immune response regulation, inflammation
and development [25]. It is also active in some tumors, during
chemotherapy response and under oxidative stress [38–40]. In
fact, NF-kB activation by many agents can be abrogated by
antioxidants [23,24]. Moreover, it is known that the antioxidant
enzyme MnSOD is transcriptionally activated through NF-kBi n
response to oxidative stress [41,42,21,22]. NF-kB is generally
accepted to be activated by the nuclear DNA damage exerted by
CPT [19]. However, DNA damage might not be the only process
by which CPT triggers NF-kB, as the antioxidant pyrrolidine
dithiocarbamate (PDTC) is very effective in abolishing NF-kB
activation by the drug [23].
There is no information about NF-kB involvement in CoQ
biosynthesis regulation, which positively responds to oxidative
stress conditions such as vitamin E withdrawal and aging [43–45].
Our results demonstrate that NF-kB is able to specifically bind to
both COQ7 kB sites in response to CPT. Super-shift assays
indicated that the dimer that recognizes the kB2 site is composed
of both p65 and p50 subunits and the homodimer p50/p50
probably binds to kB1. It is important to note that NF-kB
activation by CPT has been extensively studied. However, assays
have generally been done using consensus sequences correspond-
ing to either immunoglobulin heavy chain gene [19] or the HIV
enhancer [23], but we have used here a consensus sequence
specific for COQ7 gene. Thus, although it has been defined p65/
p50 as the only complex involved in CPT- mediated NF-kB
activation [23], we can not rule out the possibility that the COQ7
kB2 site is recognized by a p50/p50 homodimer.
The specific binding of NF-kB to a DNA probe does not
demonstrate its functionality in vivo but luciferase assays demon-
strated that COQ7 was transcriptionally activated by CPT. The
different constructs assayed have shown that it was necessary to
Figure 4. EMSA analysis of NF-kB. EMSAs were performed with
H460 nuclear extracts from CPT treated and non-treated cells (CT) with
digoxigenin-labeled kB1 probe. A. Time course of the NF-kB binding to
the kB1 site in response to CPT. B. Competition assay using 10-fold
molar concentration of unlabeled normal kB1 probe (specific) and a
non related probe (non-specific) competitor. C. Antibody super shift
analysis of NF-kB binding to the kB1 site in the COQ7 promoter. Nuclear
extracts from 6 hours-CPT treated H460 cells were incubated with or
without different NF-kB subunits antibodies. Images are representative
of various EMSAs performed.
doi:10.1371/journal.pone.0005301.g004
Figure 5. EMSA analysis of NF-kB. EMSAs were performed with
H460 nuclear extracts from CPT treated and non-treated cells with
digoxigenin-labeled labeled kB2 probe. A. Time course of the NF-kB
binding to the kB2 site in response to CPT. B. Competition assay using
10-fold molar concentration of unlabeled normal kB2 probe (specific)
and a non related probe (non-specific) competitor. C. Antibody super
shift analysis of NF-kB binding to the kB2 site in the COQ7 promoter.
Nuclear extracts from 6 hours-CPT treated H460 cells were incubated
with or without different NF-kB subunits antibodies. Images are
representative of various EMSAs performed.
doi:10.1371/journal.pone.0005301.g005
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respond to the drug. A construct containing 1000 bp of the 59
flanking region (pGL3-1) was not able to respond to CPT. TESS
analysis of the sequence of this region shows the presence of
putative binding sites for Sp1 and RXR transcription factors.
Interestingly, NF-kB and Sp1 have been found to cooperatively
bind to DNA in different promoter systems [46–48]. Moreover,
interaction between NF-kB and Sp1 has been also found in the
Figure 6. Functional analysis of the promoter of the human COQ7 gene. A. Schematic diagram of the 59 flanking region (blue box), 59 UTR
sequence (thick line), first exon (green arrow) and beginning of the first intron (thin line) of COQ7 gene. Schematic illustration of the regions
encompassed in the various luciferase reporter constructs used in the functional analysis. Triangles indicate deletions inside the different kB sites. B.
Firefly luciferase activities expressed in HeLa cells transfected with two different reporter constructs (pGL3-1 and pGL3-2) under different treatments.
Luciferase activity was normalized on the basis of the b-gal activity constitutively expressed by the co-transfected plasmid pC110. Results are the
mean6SD of at least three independent transfection experiments. BAY indicates the presence of the NF-kB inhibitor Bay 11-7085. * P,0.05, **
P,0.001, a P=0.05 between the treatment and its control. C. Deletion analysis of the COQ7 putative kB sites. The kB sites were partially deleted as
indicated in blue. CPT responsiveness of these constructs was assayed as described before. Results are expressed as the relative CPT/control response
in transfected cells. Results are the mean6SD of three independent transfection experiments. D. Western blot analyzing the presence of different NF-
kB system elements on the cytosolic or nuclear compartments. Punceau staining of the membrane used for the Western blot is presented as loading
control.
doi:10.1371/journal.pone.0005301.g006
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the other hand, RXR has been shown to be required for CoQ
biosynthesis and its induction by cold exposure in mice [35].
Both basal binding and CPT-activated COQ7 mRNA transcrip-
tion promoter are inhibited by the NF-kB inhibitor Bay 11-7085,
which targets the NF-kB activating IkB kinase complex (IKK) [27],
supporting the NF-kB participation in the transcriptional regulation
of the gene. Inhibition of NF-kB by Bay-117085 not only avoided
the CPT-dependent increase of COQ7 mRNA, but also the increase
in CoQ levels. Additionally, viability assays have shown that the
inhibition of the transcription factor sensitizes cells to die by CPT.
All these results further support the hypothesis that CPT triggers a
NF-kB survival response involving the antioxidant CoQ.
The treatment of cells with chemotherapeutic compounds such
as CPT induces cell death but some cell types can survive via
activation of antioxidant pathways [49], including the increase of
CoQ biosynthesis [8]. Here we have shown that CPT increases
ROS production. This situation activates NF-kB that, among
other factors, induces the expression of COQ7 gene by transcrip-
tional regulation, which, in turn, increases CoQ biosynthesis.
These findings contribute to the understanding of the proteins that
participate in the enzymatic process of CoQ biosynthesis, which
will help further our understanding of the CoQ10 biosynthetic
pathway and its involvement in CoQ deficiency syndrome in
humans.
Materials and Methods
Cell cultures
Non-small lung cancer cells (NSLC) line H460 was a gift from
Dr. PJ Woll (CRC Department of Clinical Oncology, City
Hospital, Nottingham, UK). HeLa cells were purchased from the
American Type Culture Collection. DU145 WT and DU145
RC0.1 were a generous gift from Dr. Pommier (Laboratory of
Molecular Pharmacology, Center of Cancer Research, National
Cancer Institute/NIH Bethesda, MD). H460, parental DU145
and DU145 RC0.1 cells were cultured at 37uC in RPMI-1640
medium supplemented with L-glutamine, an antibiotic/antimy-
cotic solution (Sigma), and 10% fetal bovine serum. HeLa cells
were cultured in DMEM medium in the same conditions.
Cell viability measurement
Dead cells become propidium iodide (PI) permeable as a
consequence of the lost of plasma membrane integrity. Thus, cell
viability was determined by PI (10 mg/ml) staining and flow
cytometry analysis.
Measurement of CoQ levels
Lipid extraction from cells samples was performed as described
previously [8]. CoQ6 or CoQ9 were used as internal standard.
Cell samples were lysed with 1% SDS and vortexed for 1 min. A
mixture ethanol:isopropanol (95:5) was added and the samples
were vortexed for 1 min. To recover CoQ, 5 ml of hexane was
added and the samples were centrifuged at 10006g for 5 min at
4uC. The upper phases from three extractions were recovered and
dried on a rotatory evaporator. Lipid extract were suspended in 1
ml of ethanol, dried in a speed-vac and kept at 220uC until
analysis. Samples were suspended in the suitable volume of
ethanol prior to HPLC injection. Lipid components were
separated by a Beckmann 166-126 HPLC system equipped with
a 15-cm Kromasil C-18 column in a column oven set to 40 uC,
with a flow rate of 1 ml/min and a mobile phase containing 65:35
methanol/n-propanol and 1.42 mM lithium perchlorate. CoQ
levels were analyzed with an ultraviolet (System Gold 168),
electrochemical (Coulochem III ESA) and radioactivity detector
(Radioflow Detector LB 509, Berthod Technologies) when
necessary.
ROS measurement by flow cytometry
Free radical measurement was achieved by H2DCF-DA or CM-
H2DCF-DA (Molecular Probes). These compounds are cell-
permeant indicators for reactive oxygen species that are
nonfluorescent until removal of the acetate groups by intracellular
esterases and oxidation occurs within the cell. H460 cells were
seeded in 35-mm dishes and treated when confluence was reached.
Cells were incubated with 10 mM CM-H2DCFDA or H2DCF-DA
for the last 30 min of treatment, washed and detached with
trypsin. Flow cytometric analysis was performed with Epics
H XL
cytometer (Coulter) after trypsin removal. Population was selected
using FS and SS and the fluorescence was measured by FL1
detector (525620 nm). H2O2 was used as a positive control for
detection of cellular free radicals.
Immunoblotting
Mitochondrial, nuclear or cytosolic fractions were resolved in a
SDS-polyacrilamide gel electrophoresis (SDS-PAGE) (with variable
acrilamide percentage according to the molecular weight of the
protein of interest) and transferred to nitrocellulose membranes in a
semi-dry transfer system (Trans-Blot, Biorad). After verification of
equal loading using Ponceau S, membranes were blocked with 5%
non-fat milk in TBS buffer (1 h room temperature or over night at
4uC) and stained with the appropriate primary antibodies (2 h at
room temperature or over night at 4uC). Anti IkBa,I kBb p50 and
actin were diluted 1:1000. Incubation with anti rabbit (1:10000) or
anti mouse (1:5000) HRP-conjugated secondary antibodies was
performed during 2 hours at room temperature. Immunolabeled
proteins were detected by membrane exposure to X-ray film after
incubation in enhanced chemiluminiscence reagent (Immun-Star
HRP Substrate Kit, Biorad).
Real Time PCR
Relative expression levels were determined by real-time PCR.
Cells were seeded in 35-mm plates and treated appropriately.
Floating-dead cells were discarded and monolayer was washed
with cold PBS. Total RNA from cells cultures was extracted with
the TriPure Isolation Reagent (Roche). RNA preparation was
treated for DNA removal with deoxiribonuclease I (Sigma) and
cDNA was obtained from 1 mg of RNA by using the iScript cDNA
Synthesis Kit (Biorad). Real Time PCR was performed in a
MyiQ
TM Syngle Color Real Time PCR Detection System (Biorad)
coupled to a Biorad conventional thermocycler. Primers for COQ7
and the housekeeping gene were designed with the Beacon
Designer 4 software. Amplification was carried on with iQ SYBR
Green supermix (Biorad) with the following thermal conditions: 30
sa t9 5 uC and 35 cycles of 30 s at 94uC, 30 s at 60uC and 30 s at
72uC. All the results were normalized to the levels of actin mRNA.
At least three independent experiments were performed and the
results averaged.
Electrophoretic mobility shift assay (EMSA)
Synthetic oligonucleotides encompassing the putative kBs i t e so f
the promoter region of the human COQ7 gene (kB1F- TAAAG-
CAGGAAATACCGTGCCT; kB1R- AGGCACGGTATTTC-
CTGCTTTA; kB2F-AGCTAGGGAATTTTCGCTTGA; kB2R-
TCAAGCGAAAATTCCCTAGCTC) were purchased from MWG
Biotech AG (Germany) as single stranded oligonucleotides. Digox-
igenin labelling of the oligonucleotides was performed following the
NF-kB in CoQ Biosynthesis
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complementaryforwardand reverse oligonucleotidesweredenatured
2m i na t9 5 uC and placed at room temperature for 30 min to
generate double stranded oligonucleotides. A reaction was set up in a
final volume of 20 ml in 1X reaction buffer (0.2M potassium
cacodylate, 25 mM Tris-HCl, 0.25 mg/ml BSA (pH 6.6) at 25uC)
containing 4 pmol of double stranded oligonucleotide, 5 mM CoCl2,
0.05 mM digoxigenin-ddUTP and 20 U of terminal transferase and
incubated 15 min at 37uC. The reaction was stopped with 2 mlo f0 . 2
M EDTA (pH 8.0). Resultant labelled probe was diluted to a final
concentration of 16 fmol/ml with TNE (Tris-HCl 10 mM; NaCl 100
mM; EDTA 1 mM).
Preparation of nuclear extract was performed by an adaptation of
the protocol described by Schreiber and co-workers [50]. Briefly, the
day before the treatment H460 cells were seeded at a density of 8 10
4
cells/cm
2. After the treatment, cells were directly lysed on the flask by
the addition of an hypoosmotic buffer (10 mM Hepes, 10 mM KCl,
0.1 mM EDTA, 0.1 mM EGTA, 0.625% NP-40, 1 mM DTT, 0.5
mM PMSF and protease inhibitor cocktail (Sigma)). Cell lysate was
incubated for 5 min on ice, vigorously vortexed during 10 s and
centrifuged at maximum speed for 30 s. Supernatant was reserved as
cytoplasmic extract and stored at 280uC. The pellet was resuspended
inanhyperosmoticbuffer(20mMHepes,0.4MNaCl,1mMEDTA,
1m ME G T A ,1m MD T T ,1m MP M S Fa n dp r o t e a s ei n h i b i t o r
cocktail (Sigma)) and incubated on ice during 15 min in agitation.
Extracts werecentrifuged at 16000 g 30 min at 4uC and supernatants
were recovered as nuclear protein extracts without DNA.
Electrophoretic mobility shift assays (EMSAs) were performed
following the DIG Gel Shift 2nd Generation kit (Roche) indications:
20 mg of nuclear extract were incubated in 1X Binding Buffer (20
mM Hepes pH 7.6, 1 mM EDTA, 10 mM (NH4)SO4, 1 mM DTT,
0.2% Tween-20, 30 mM KCl), 1 mg poly [d(I-C)], 0.1 mg poly L-
lysine and 64 fmol of DIG-labelled probe. Competition assays were
performed in the presence of a 10X excess of cold specific or non
specific (Oct2A: Forward strand GTACGGAGTATCCAG-
CTCCGTAGCATGCAAATCCTCTGG; Reverse strand CCT-
CATAGGTCGAGGCATCGTACGTTTAGGAGACCAGCT)
probe. For supershift assays 0.4 mg of rabbit polyclonal antibody
(p65, p50 or p52) was pre-incubated with the nuclear extracts for 30
min on ice before the binding incubation. Samples were loaded in a
4–8% native acrilamide: bisarilamide (30:1) gel (0.5X TBE buffer)
and electrophoresed at 150 V in 0.5X TBE buffer. Electrotrans-
ference to a nitrocellulose membrane (Hybond
TM–N+, Amersham)
was performed with a Trans-Blot Semi-Dry system (Biorad)
following the manufacturer’s instructions. Samples were fixed to
the membrane by UV-crosslinking (70 mJ/cm
2). Dig-labelled
probes were detected with anti-digoxigenin and visualized with
the chemiluminescent substrate CSPD from the DIG Gel Shift 2nd
Generation Kit (Roche) and the membrane exposure to an X-ray
film.
Cloning of COQ7 promoter region and generation of
luciferase reporter constructs
Inserts in pGL3-1 and pGL3-2 vectors were generated by PCR
(special thermal conditions: 6 cycles with an annealing temperature
of 42uC, followed by a Touch Down-PCR starting at an annealing
temperature of 62uC and finishing at 42uC) from the BAC clone
RP11-626G11 (AC099518; BACPAC Resource Centre, Children’s
Hospital Oakland Research Institute). COQ7 promoter region was
first cloned into pGEM-T Easy Vector (Promega) using primers
containing the restriction enzyme sites for SacI (59) and HindIII (39):
hCQ7pSacIF (GTAGAGCTCTCCAAGGGTGTAA),CQ7pHin-
dIIIR (GTTAAGCTTGTCCTGTTCACAG), for pGL3-1, and
hCQ7pSacI3 (GTAGAGCTCACAGAGGGAGG) and
CQ7pHindIIIR for pGL3-2. Primers were designed to amplify
the 59 flanking region of the COQ7 gene (1000 pb for pGL3-1 and
2150 for pGL3-2), the 59 UTR region (60 bp), the complete first
exon (73 bp) and, partially, the first intron of the gene (487 bp).
Once verified by sequencing, fragments were subcloned into the
pGL3basic vector (a generous gift from Dr. Blesa, Centro de
Investigacio ´n Prı ´ncipe Felipe, Valencia, Spain). Simple and double
kB sites deletions for the pGL3-2DkB1, pGL3-2DkB2 and pGL3-
2DkB1+2 vectors were carried out by using the Quikchange II XL
Site-Directed Mutagenesis Kit (Stratagene) with the following
primers pairs: for kB1 site, CCTTCCACGTAGGTAAAGCAGC-
GTGCCTTGTTAATAAGTAAT and ATTACTTATTAA-
CAAGGCACGCTGCTTTACCTACGTGGAAGG; for kB2 site
CGGTCTAGCGAGCTAGGCGCTTGAGGTTTGGGTC and
ACCCAAACCTCAAGCGCCTAGCTCGCTAGACCG.
Reporter gene assays
Endotoxin-free plasmids were obtained by Qiagen EndoFreeH
Plasmid Maxi Kit, to avoid unspecific activation of NF-kB. HeLa
cells were transfected with FuGENE 6 (Roche) following the
manufacturer’s instructions. Briefly, the day before transfection,
2.9610
5 cells were plated in 12 well dishes (DMEM 10% serum
without antibiotics). One hour before transfection, media was
changed. For each single transfection 2.2 ml of FuGENE reagent
were diluted in 50 ml of non supplemented OPTIMEM media
(Gibco) and incubated for 10 minutes at room temperature. 0.74
mg of total DNA was added to the FuGENE diluted transfection
mixture and further incubated for 30 minutes at room temper-
ature. Then, the transfection reagent/DNA complex was added to
the cells. Cells were co-transfected with pGL3-1 or pGL3-2 (0.37
mg) and pCH110 (0.37 mg), a plasmid containing the b-
galactosidase gene regulated by a constitutive promoter (a
generous gift from Dr. Carrio ´n, Universidad Pablo de Olavide,
Sevilla, Spain). The transfection proceeded for 48 hours before
cells were appropriately treated. After that, death cells were
discarded and monolayer was washed with cold PBS and lysed in
100 ml of Luciferase Lysis Buffer (Promega). Lysates were
vigorously vortexed for 10 s and centrifuged 12000 g during 15
min. Aliquots were stored at 280uC until used. b-galactosidase
activity was quantified in the same extracts used for luciferase
activity measurement. 30 ml of lysate sample was mixed with 20 ml
of H2O and 50 ml of reaction buffer (200 mM Na2HPO4 pH 7.3, 2
mM MgCl2, 100 mMb-mercaptoethanol, 1.33 mg/ml ONPG [o-
nitrophenyl-b-D-galactopyranoside]). Samples were incubated for
45 min/ 1 h at 37uC and b-galactosidase activity was
spectrophotometrically measured at 405 nm in a Sunrise plate
reader (Tecan Austria GmbH) coupled to the Magellan software.
Luciferase activity was measured by a manual luminometer
Luminoskan TL Plus (Thermo LabSystems). 2 ml of cell extract
were added to 50 ml of reaction buffer (Luciferase Assay Buffer
from Promega Luciferase Assay System kit) in a luminometer
cuvette. Light intensity was measured inside the detection linear
range. Results are expressed as relative intensity units (LRU).
Definitive results are expressed as relative LRU/ b-gal activities.
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